ClinicalTrialsFinder

Relapsed or Refractory Peripheral T-cell Lymphoma Clinical Trials in Taipei

1 recruitingTaipei, Taiwan

Showing 1–1 of 1 trials

Recruiting
Phase 2

Chidamide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (R/R PTCL)

Relapsed or Refractory Peripheral T-cell Lymphoma
Great Novel Therapeutics Biotech & Medicals Corporation33 enrolled5 locationsNCT05833724